|
시장보고서
상품코드
2054724
섬유아세포 증식 인자(FGF) 시장 : FGF 분자 유형별, 원료별, 제품 형태별, 용도별, 최종사용자별, 사용 방법별, 치료 영역별, 지역별Fibroblast Growth Factors Market, By Type of FGF Molecule (FGF2, FGF21, FGF19, FGF18, FGF7, FGF9, FGF1, FGF23, FGF8, FGF4, and Other FGFs ), By Source, By Product Form, By Application, By End User, By Usage, By Therapeutic Area, By Geography |
||||||
섬유아세포 증식 인자(FGF) 시장은 2026년에 39억 3,000만 달러로 추정되고 있으며, 2033년까지 70억 9,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 8.8%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 39억 3,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 8.80% | 2033년 시장 규모 예측 : | 70억 9,000만 달러 |
전 세계 섬유아세포 성장인자(FGF) 시장은 생명공학 및 제약 산업에서 매우 중요한 부문을 차지하고 있으며, 세포의 증식, 분화, 이동 및 생존 과정에서 핵심적인 역할을 수행하는 신호전달 단백질 군을 포괄하고 있습니다. 섬유아세포 성장인자에는 20유형 이상의 다양한 구성 요소가 포함되어 있으며, 상처 치유, 혈관 신생, 배아 발생, 조직 재생 등 다양한 생물학적 기능을 조절하므로 다양한 질환의 치료에 있으며, 매우 중요한 치료 표적이 되고 있습니다.
이러한 다기능 단백질은 심혈관 질환, 신경계 질환, 대사성 질환 및 암 치료에 대한 잠재적 응용 가능성뿐만 아니라, 재생의학 및 조직공학 분야에서도 유망한 결과를 보여주고 있으며, 연구자와 제약 기업으로부터 큰 주목을 받고 있습니다. 이 시장에는 재조합 단백질, 유전자 치료 벡터, FGF 신호 전달 경로를 표적으로 하는 저분자 조절제 등 다양한 제품 형태가 포함되어 있습니다. 생명공학 연구개발에 대한 투자 증가, 만성질환 유병률 상승, 그리고 첨단 치료 솔루션에 대한 수요 증가에 힘입어, 섬유아세포 성장인자(FGF) 시장은 기존 대형 제약사와 새로운 FGF 기반 치료제 및 진단 툴 개발에 주력하는 신생 바이오기술 기업 양측에 의해 주도되며, 놀라운 성장세를 보이고 있습니다.
시장 역학
전 세계 섬유아세포 성장인자 시장은 혁신적인 치료 개입이 필요한 당뇨병, 심혈관 질환, 신경퇴행성 질환 등의 만성질환 유병률 급증과 더불어, 첨단 재생의료 솔루션을 요구하는 전 세계적인 고령화 추세 등 몇 가지 주요 촉진요인에 힘입어 성장하고 있습니다. 제약 회사와 생명공학 기업의 연구개발 활동에 대한 투자 증가, 그리고 생명공학 연구에 대한 정부의 지원 정책과 자금 지원이 시장 성장을 크게 가속화하고 있습니다.
또한 상처 치유, 조직 공학, 미용 시술 분야에서 FGF의 적용 범위가 확대됨에 따라 새로운 수입원과 시장 기회가 창출되고 있습니다. 그러나 시장에는 광범위한 임상 시험이나 안전성 평가가 필요한 엄격한 규제 승인 절차 등, 개발 기간의 장기화나 막대한 자금 투자를 초래하는 큰 제약 요인도 존재합니다.
FGF 기반 치료법의 높은 비용과 재조합 단백질 제조의 복잡성은, 특히 가격에 민감한 지역에서 시장 침투의 큰 장벽이 되고 있습니다. 또한 통제 불가능한 세포 증식이나 종양 형성의 위험을 포함한 FGF 치료와 관련된 잠재적인 부작용 및 안전성 우려는 규제상의 장벽이 되어, 광범위한 보급을 제한하고 있습니다.
그럼에도 불구하고 이 시장은 치료 효과를 높이는 동시에 부작용을 최소화하는 맞춤형 의료, 병용 요법, 그리고 새로운 약물전달 시스템에 대한 새로운 응용을 통해 큰 기회를 제시하고 있습니다. 정밀 의학에 대한 관심 증가, 유전자 치료 기술의 발전, 그리고 저침습 치료법에 대한 수요 확대는 특히 의료 인프라가 급속히 구축되고 첨단 치료법에 대한 인식이 높아지고 있는 개발도상 지역에서 새로운 시장 가능성을 열어줄 것으로 예상됩니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 매출 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 지표(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략)를 바탕으로 전 세계 섬유아세포 성장인자 시장의 주요 기업을 분석하고 있습니다.
- 이 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계의 섬유아세포 성장인자 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 섬유아세포 성장인자 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 섬유아세포 증식 인자(FGF) 시장 : FGF 분자 유형별, 2021-2033년
제5장 세계의 섬유아세포 증식 인자(FGF) 시장 : 원료별, 2021-2033년
제6장 세계의 섬유아세포 증식 인자(FGF) 시장 : 제품 형태별, 2021-2033년
제7장 세계의 섬유아세포 증식 인자(FGF) 시장 : 용도별, 2021-2033년
제8장 세계의 섬유아세포 증식 인자(FGF) 시장 : 최종사용자별, 2021-2033년
제9장 세계의 섬유아세포 증식 인자(FGF) 시장 : 사용법별, 2021-2033년
제10장 세계의 섬유아세포 증식 인자(FGF) 시장 : 치료 영역별, 2021-2033년
제11장 세계의 섬유아세포 증식 인자(FGF) 시장 : 지역별, 2021-2033년
제12장 경쟁 구도
제13장 애널리스트의 제안
제14장 참고 문헌 및 조사 방법
KSA 26.06.17Fibroblast Growth Factors Market is estimated to be valued at USD 3.93 Bn in 2026 and is expected to reach USD 7.09 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3.93 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.80% | 2033 Value Projection: | USD 7.09 Bn |
The global fibroblast growth factors market represents a critical segment within the biotechnology and pharmaceutical industry, encompassing a family of signaling proteins that play pivotal roles in cellular proliferation, differentiation, migration, and survival processes. Fibroblast growth factors comprise over 20 distinct members that regulate various biological functions including wound healing, angiogenesis, embryonic development, and tissue regeneration, making them invaluable therapeutic targets for treating diverse medical conditions.
These multifunctional proteins have garnered significant attention from researchers and pharmaceutical companies due to their potential applications in treating cardiovascular diseases, neurological disorders, metabolic conditions, and cancer, while also showing promising results in regenerative medicine and tissue engineering applications. The market encompasses various product forms including recombinant proteins, gene therapy vectors, and small molecule modulators that target FGF signaling pathways. With increasing investments in biotechnology research, growing prevalence of chronic diseases, and rising demand for advanced therapeutic solutions, the fibroblast growth factors market is experiencing substantial growth momentum driven by both established pharmaceutical giants and emerging biotech companies focused on developing novel FGF-based therapeutics and diagnostic tools.
Market Dynamics
The global fibroblast growth factors market is propelled by several key drivers including the escalating prevalence of chronic diseases such as diabetes, cardiovascular disorders, and neurodegenerative conditions that require innovative therapeutic interventions, coupled with the growing aging population worldwide that demands advanced regenerative medicine solutions. The increasing investments in research and development activities by pharmaceutical and biotechnology companies, along with supportive government initiatives and funding for biotechnology research, are significantly accelerating market growth.
Additionally, the expanding applications of FGF in wound healing, tissue engineering, and cosmetic procedures are creating new revenue streams and market opportunities. However, the market faces considerable restraints including stringent regulatory approval processes that require extensive clinical trials and safety evaluations, leading to prolonged development timelines and substantial financial investments.
The high costs associated with FGF-based therapies and the complexity of manufacturing recombinant proteins pose significant barriers to market penetration, particularly in price-sensitive regions. Furthermore, potential side effects and safety concerns related to FGF treatments, including the risk of uncontrolled cell proliferation and tumor formation, create regulatory hurdles and limit widespread adoption.
Nevertheless, the market presents substantial opportunities through emerging applications in personalized medicine, combination therapies, and novel drug delivery systems that enhance therapeutic efficacy while minimizing adverse effects. The increasing focus on precision medicine, advancements in gene therapy technologies, and growing demand for minimally invasive treatment options are expected to unlock new market potential, particularly in developing regions where healthcare infrastructure is rapidly improving and there is growing awareness about advanced therapeutic options.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global fibroblast growth factors market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific, PeproTech, R&D Systems (Bio-Techne), Merck KGaA (Sigma-Aldrich), Abcam, Cell Signaling Technology, GenScript Biotech, Lonza Group, Miltenyi Biotec, FUJIFILM Wako Pure Chemical, Proteintech Group, MedChemExpress, Elabscience Biotech, ACROBiosystems, and STEMCELL Technologies
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global fibroblast growth factors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fibroblast growth factors market
Market Segmentation
- Type of FGF Molecule Insights (Revenue, USD Bn, 2021 - 2033)
- FGF2
- FGF21
- FGF19
- FGF18
- FGF7
- FGF9
- FGF1
- FGF23
- FGF8
- FGF4
- Other FGFs (FGF3, FGF5, FGF6, FGF10-17, FGF20, FGF22, FGF24)
- Source Insights (Revenue, USD Bn, 2021 - 2033)
- Human-Derived Recombinant FGFs
- Animal-Derived Recombinant FGFs
- Synthetic FGFs
- Cell-Free Expression FGFs
- Plasmid-Engineered FGFs
- Product Form Insights (Revenue, USD Bn, 2021 - 2033)
- Liquid FGFs
- Lyophilized FGFs
- Encapsulated FGFs
- FGF-Based Kits and Reagents
- FGF-Integrated Media Supplements
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Drug Discovery and Development
- Regenerative Medicine
- Stem Cell Research
- Tissue Engineering
- Oncology Research
- Metabolic Disease Research
- Dermatology and Wound Healing
- Orthopedics and Bone Regeneration
- Cardiovascular Research
- Neuroscience Research
- Toxicology Studies
- Other Research Applications
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Pharmaceutical Companies
- Biotechnology Companies
- Academic and Research Institutes
- CROs
- CMOs/CDMOs
- Hospitals and Clinical Research Centers
- Regenerative Medicine Centers
- Usage Insights (Revenue, USD Bn, 2021 - 2033)
- In-Vitro Use
- In-Vivo Preclinical Use
- Clinical-Stage Use
- Injectable FGFs
- Topical FGFs
- Implant/Scaffold-Integrated FGFs
- Therapeutic Area Insights (Revenue, USD Bn, 2021 - 2033)
- Oncology
- Metabolic Disorders
- Cardiovascular Disorders
- Musculoskeletal Disorders
- Neurological Disorders
- Endocrine Disorders
- Dermatological Disorders
- Gastrointestinal Disorders
- Rare Genetic Disorders
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Thermo Fisher Scientific
- PeproTech
- R&D Systems (Bio-Techne)
- Merck KGaA (Sigma-Aldrich)
- Abcam
- Cell Signaling Technology
- GenScript Biotech
- Lonza Group
- Miltenyi Biotec
- FUJIFILM Wako Pure Chemical
- Proteintech Group
- MedChemExpress
- Elabscience Biotech
- ACROBiosystems
- STEMCELL Technologies
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Fibroblast Growth Factors Market, By Type of FGF Molecule
- Global Fibroblast Growth Factors Market, By Source
- Global Fibroblast Growth Factors Market, By Product Form
- Global Fibroblast Growth Factors Market, By Application
- Global Fibroblast Growth Factors Market, By End User
- Global Fibroblast Growth Factors Market, By Usage
- Global Fibroblast Growth Factors Market, By Therapeutic Area
- Global Fibroblast Growth Factors Market, By Region
3. Market Dynamics, Regulations, And Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Fibroblast Growth Factors Market, By Type of FGF Molecule, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- FGF2
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- FGF21
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- FGF19
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- FGF18
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- FGF7
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- FGF9
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- FGF1
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- FGF23
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- FGF8
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- FGF4
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other FGFs (FGF3, FGF5, FGF6, FGF10-17, FGF20, FGF22, FGF24)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Fibroblast Growth Factors Market, By Source, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Human-Derived Recombinant FGFs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Animal-Derived Recombinant FGFs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Synthetic FGFs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cell-Free Expression FGFs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Plasmid-Engineered FGFs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Fibroblast Growth Factors Market, By Product Form, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Liquid FGFs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Lyophilized FGFs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Encapsulated FGFs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- FGF-Based Kits and Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- FGF-Integrated Media Supplements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Fibroblast Growth Factors Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Drug Discovery and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Regenerative Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Stem Cell Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Tissue Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Oncology Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Metabolic Disease Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Dermatology and Wound Healing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Orthopedics and Bone Regeneration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cardiovascular Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Neuroscience Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Toxicology Studies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other Research Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Fibroblast Growth Factors Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- CROs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- CMOs/CDMOs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Hospitals and Clinical Research Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Regenerative Medicine Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Fibroblast Growth Factors Market, By Usage, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- In-Vitro Use
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- In-Vivo Preclinical Use
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Clinical-Stage Use
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Injectable FGFs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Topical FGFs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Implant/Scaffold-Integrated FGFs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Fibroblast Growth Factors Market, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cardiovascular Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Musculoskeletal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Endocrine Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Dermatological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Gastrointestinal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Rare Genetic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
11. Global Fibroblast Growth Factors Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026,2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type of FGF Molecule, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Usage, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type of FGF Molecule, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Usage, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type of FGF Molecule, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Usage, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type of FGF Molecule, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Usage, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type of FGF Molecule, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Usage, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type of FGF Molecule, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Usage, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
12. Competitive Landscape
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PeproTech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- R&D Systems (Bio-Techne)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA (Sigma-Aldrich)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abcam
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cell Signaling Technology
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GenScript Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lonza Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Miltenyi Biotec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- FUJIFILM Wako Pure Chemical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Proteintech Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- MedChemExpress
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Elabscience Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ACROBiosystems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- STEMCELL Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About us
